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条件下不稳定，容易聚集，造成 PDT 效果降低，并且 PSs 在靶组织和细胞中的
聚集量较低而不适宜临床应用。为了克服 PSs 的溶解性和靶向性的困难，本文采
用介孔二氧化硅（Mesoporous silica nanoparticles, MSNs）作为 PSs 的药物载体，






成出尺寸 50-60 nm，孔径 2-4 nm 的球形 MSNs。采用固相合成法制备 ZnPcTC，
使用 N,N-二琥珀酰亚胺基碳酸酯（N,N’-Disuccinimidyl carbonate, DSC）将
ZnPcTC 的羧基活化，MSNs 的表面使用硅烷偶联剂 3-氨丙基三甲氧基硅烷
（3-Aminopropyltrimethoxysilane, APTMS）进行氨基化，并与羧基活化的 ZnPcTC
以共价键的方式连接，制备成 MSNs 共价偶联 ZnPcTC（MSNs-NH-ZnPcTC）体
系用于 PDT 研究。通过 SEM 和 TEM 观察形貌与尺寸，红外、XRD、热重等测
试手段表征其组成与结构，紫外可见吸收分光光度计及荧光光谱仪表征其光物理
化学性质。MSNs-NH-ZnPcTC 的光动力活性测试，使用波长为 680 nm 的红光照
射不同的时间间隔（0-300 s）后，观察 1O2 指示剂 1,3-二苯基异苯并呋喃（DPBF）
的吸光度值变化，尤其是在 417 nm 处，吸光度值随光照时间而降低。另外，通
过光稳定性实验证实，MSNs 能有效保护 ZnPcTC，防止光敏剂被光过早降解，
提高光稳定性，说明 MSNs-NH-ZnPcTC 不仅光动力活性强，并且能对所载光敏


















依次偶联到活化后的 MSNs 上，构成 PEG-PEI-MSNs/ZnPc 药物运输体系，对该
体系进行理化性质表征，使用 TEM 观察其形貌和尺寸，紫外可见分光光度计及
荧光光谱仪探讨其光物理化学性质，光动力活性测试使用波长为 680 nm 的红光
照射不同的时间间隔（0-12 min）后，观察 1O2 指示剂 9,10-蒽基-双（亚甲基）二
丙二酸（ABDA）的荧光发射光谱在 407, 431 以及 457 nm 处的荧光强度随着光























Photodynamic Therapy (PDT) is emerging as a promising non-invasive treatment 
modality for various neoplastic and non-neoplastic pathologies, particularly for 
superficial tumors. This treatment involves either local or systemic administration of 
certain therapeutic molecules called photosensitizers (PSs), which preferentially 
localizes within the tumor, follows by irradiation of the tumor site with appropriate 
wavelength of light. Most of the photosensitizers are lipophilic compounds and under 
physiological conditions are essentially insoluble, unstable, and easily aggregated in 
water, which would reduce their PDT efficiency. Moreover, the accumulation 
selectivity to specific cells or tissues is usually too low for clinical use. To overcome 
the solubility and target specificity limits of PSs, this article employed mesoporous 
silica nanoparitcles (MSNs) as a carrier for PSs, have fabricated zinc 
tetracarboxylphthalocyanine (ZnPcTC) loaded into MSNs through chemical covalent 
bongding and multifunctional zinc phthalocyanine (ZnPc) loaded MSNs for PDT. The 
characterization and photoactivity of these two drug delivery systems were studied. 
The main research contents are as follows: 
(1) The synthesis and characterization of ZnPcTC loaded into MSNs through 
chemical covalent bongding 
Using organic templates method, cetyltrimethylammonium bromide (CTAB) 
acted as both a template and surfactant, tetraorthosilicate (TEOS) was used as the 
source of silica and L-lysine was used as a catalyst, spherical MSNs with tunable pore 
size (2-4 nm) and outer diameter (50-60 nm) were successfully prepared by changing 
the ratio of the raw materials and the rate of stirring. The ZnPcTC was synthesis using 
solid phase method. After activating the carboxyl groups of ZnPcTC with 
N,N’-Disuccinimidyl carbonate (DSC), MSNs were modified with 
3-Aminopropyltrimethoxysilane (APTMS) for further connection. ZnPcTC 















ZnPcTC-modified MSNs (MSNs-NH-ZnPcTC) for PDT study. The morphologies and 
size of MSNs-NH-ZnPcTC were observed by TEM. The structure and constitute were 
studied by FT-IR, XRD and TGA, when UV-Vis and fluorescence spectrophotometer 
were used to evaluate the photophysical and photochemical properties. In the 
photoactivity experiment, the generation of singlet oxygen (
1
O2) by ZnPcTC was 
measured after MSNs-NH-ZnPcTC were exposed to 680 nm light in the presence of 
1,3-diphenylisobenzofuran (DPBF). The reaction was monitored 
spectrophotometrically by recording the decrease in optical density at 417 nm, which 
demonstrated the PDT efficiency of MSNs-NH-ZnPcTC. A direct comparison of the 
stability of free ZnPcTC and MSNs-NH-ZnPcTC was demonstrated that MSNs could 
keep the photostability of ZnPcTC and protect it against bleaching. 
(2) The synthesis and characterization of multifunctional zinc phthalocyanine 
(ZnPc) loaded MSNs 
The surface of MSNs was activated by carbonyldiimidazole (CDI) and ZnPc was 
incorporated into the MSNs by physical adsorption. Polyethylenimine and 
poly(ethylene glycol) coupled to CDI activated MSNs successively. The physical and 
chemical properties and photodynamic activity of PEG-PEI-MSNs/ZnPc were studied. 
The morphologies and size of MSNs/ZnPc were observed by SEM and TEM. The 
UV-Vis and fluorescence spectrophotometer were used to evaluate the photophysical 
and photochemical properties of PEG-PEI-MSNs/ZnPc. After irradiation with 680 nm 
light for different time internal (0-12 min), the generation of singlet oxygen (
1
O2) by 
ZnPc was detected by 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA). 
The reaction was monitored spectrophotometrically by recording the decrease in 
fluorescence intensity at 407, 431 and 456 nm when excited at 380 nm. It 
demonstrated the PDT efficiency of PEG-PEI-MSNs/ZnPc. Confocal microscopy, 
MTT, mitochondrial membrane potential measurement and in vivo experiment 
confirmed that PEG-PEI-MSNs/ZnPc is a promising PDT agent. 
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照射治疗。PDT 过程如图 1-1 所示[5]。 
 
 
图 1-1 光动力治疗的原理图[5] 
Fig. 1-1 Schematic of tumor phototherapy using a photosensitizer (photodynamic 
therapy) 
 
PDT 治疗肿瘤最早追溯到 1900s[6]，从 1960s 和 1970s 开始进行细胞和动物



















学反应[10,11]。PDT 的光物理化学机制如图 1-2 所示[12]。 
 
 
图 1-2 光敏剂引发的 PDT 的反应动力学（I 型和 II 型）[12] 






























过程中，这些 ROS 和 1O2 对细胞器和一些生物分子造成光损伤，从而引发细胞
死亡。一般认为 1O2 是 PDT 效果的主要决定因素
[2,15-17]。 
PDT 的抗肿瘤效果的体内作用机制十分复杂，如图 1-3 所示，主要涉及到几
个不同但相互关联的机制[14,18]。首先，PDT 直接作用于肿瘤细胞，由光敏剂受光
激发生成的 ROS 引发细胞坏死或者凋亡。其次，PDT 能破坏肿瘤血管系统，导
致血管崩溃和栓塞[19]，通过切断肿瘤的养分供应从而破坏肿瘤。最后，PDT 能
激活抗肿瘤的免疫系统[20]，三者结合能在最大程度上发挥 PDT 的作用。 
 
 
图 1-3 PDT 的体内作用机制[14] 
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图 1-4 细胞离血管距离越远，治疗效果越差的可能原因[22] 






抑制的疗法，而 PDT 是免疫激活的。PDT 通过释放前炎症因子，如肿瘤坏死因
子-（TNF-），白细胞介素-1（IL-1）和 IL-6 吸引白细胞如树突细胞（DCs）
和中性粒细胞，进而引发急性炎症反应。另外，PDT 引起肿瘤细胞坏死和凋亡，
刺激肿瘤细胞衍生抗原的产生。PDT 造成的肿瘤微环境的变化会提高 DCs 抗原





































目前临床研究中的三类光敏剂，如表 1-1 所示[30]。 
第一类为卟啉类光敏剂。通过纯化和转变，血卟啉（Hp）衍生物已被制备
成商品化的光敏剂 Photofrin○R 等[37]。该类光敏剂是目前最主要的 PDT 抗肿瘤光
敏剂，多用于治疗早期肺癌、浅表性胃癌、食管腺癌、子宫颈癌和膀胱癌等。最
























第一章 绪 论 
6 
表 1-1 光敏剂的分类[30] 
Table 1-1 Photosensitizer families 
卟啉类 叶绿素类 染料类 
血卟啉衍生物 二氢卟吩类 酞菁类 
苯并卟啉衍生物 紫红素类 萘酞菁类 















属离子的酞菁光动力活性低，而具有 8 或 18 电子闭壳的离子，如 Al3+, Zn2+, Mg2+
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